Assessment of allogenic 2-unit RBC apheresis: Donors, products and patients.

被引:0
|
作者
Desbois, I
Delain, M
Adjou, C
Rapp, MJ
Coffe, C
Caillot, D
Kientz, D
Follea, G
机构
[1] Etab Francais Sang, Strasbourg, France
[2] Etab Francais Sang, Tours, France
[3] Etab Francais Sang, Dijon, France
[4] Etab Francais Sang, Nantes, France
[5] CHU Tours, Tours, France
[6] CHU Nantes, F-44035 Nantes 01, France
[7] Ctr Hosp, Dijon, France
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:52S / 52S
页数:1
相关论文
共 50 条
  • [41] The assessment of myocardial dysfunction in septic shock patients admitted in intensive care unit by 2-dimensional speckle tracking image
    Ha, S. J.
    Kim, H. S.
    Woo, J. S.
    Kim, S. J.
    Kim, W.
    Kim, M. K.
    Kim, K. S.
    Kim, W. S.
    EUROPEAN HEART JOURNAL, 2013, 34 : 691 - 691
  • [42] Development of fast and accurate chemical hydrolysis method for CYP2D6 activity assessment using dextromethorphan as probe in a population of fibromyalgia patients.
    Daali, Y.
    Chabert, J.
    Piguet, V.
    Rebsamen, M.
    Rossier, M.
    Dayer, P.
    Desmeules, J. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 : S77 - S77
  • [43] High Concordance for Microarray Based Determination of ER, PR and HER2 Receptor Status and Local IHC/FISH Assessment Worldwide in 749 Patients.
    Wesseling, J.
    Cusumano, G.
    Tinterri, C.
    Sapino, A.
    Zanconati, F.
    Lutke-Holzik, M.
    Nguygen, B.
    Deck, K.
    Querzoli, P.
    Perin, T.
    Giardina, C.
    Seitz, G.
    Guinebretiere, J.
    Barone, J.
    Watanabe, T.
    CANCER RESEARCH, 2011, 71
  • [44] Central review of discordant samples for microarray-based ER, PR, and HER2 and local IHC/FISH assessment worldwide from 827 patients.
    Wesseling, Jelle
    Tinterri, Corrado
    Sapino, Anna
    Zanconati, Fabrizio
    Holzik, Martijn Lutke
    Nguyen, Bichlien
    Deck, Kenneth B.
    Querzoli, Patrizia
    Perin, Tiziana
    Giardina, C.
    Seitz, Gerhard
    Guinebretiere, Jean-Marc
    Barone, Julie
    Watanabe, Toru
    De Snoo, Femke
    Stork-Sloots, Lisette
    Cusumano, Pino
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (27)
  • [45] Identification of strategies for prevention of diabetic nephropathy: Control of hypertension, smoking and clinic defaulting in type 2 patients. Wolverhampton Assessment of Nephropathy in Diabetes (WAND) study.
    Rylance, PB
    McLelland, EV
    Walford, S
    Jackson, MA
    Odum, J
    Nicholas, J
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 688A - 688A
  • [46] A comparative assessment of failures and periodontal health between 2 mandibular lingual retainers in orthodontic patients. A 2-year follow-up, single practice-based randomized trial
    Wegrodzka, Ewa
    Kornatowska, Katarzyna
    Pandis, Nikolaos
    Fudalej, Piotr S.
    AMERICAN JOURNAL OF ORTHODONTICS AND DENTOFACIAL ORTHOPEDICS, 2021, 160 (04) : 494 - +
  • [47] JAK2V617F mutation screening as part of the hypercoagulable workup in the absence of splanchnic vein thrombosis: Assessment of value in a series of 664 consecutive patients.
    Pardanani, Animesh
    Lasho, Terra L.
    Hussein, Kebede
    Schwager, Susan
    Finke, Christy
    Pruthi, Rajiv K.
    Tefferi, Ayalew
    BLOOD, 2007, 110 (11) : 937A - 937A
  • [48] Assessment of urine CCL2 as a potential diagnostic biomarker for acute kidney injury and septic acute kidney injury in intensive care unit patients
    Peng, Yuan
    Wang, Qin
    Jin, Fang
    Tao, Tao
    Qin, Qihong
    RENAL FAILURE, 2024, 46 (01)
  • [49] Efficacy and tolerance of interferon-α2b in the treatment of chronic hepatitis C virus infection in haemodialysis patients.: Pre- and post-renal transplantation assessment
    Campistol, JM
    Esforzado, N
    Martínez, J
    Roselló, L
    Veciana, L
    Modol, J
    Casellas, J
    Pons, M
    de las Cuevas, X
    Piera, J
    Oliva, JA
    Costa, J
    Barrera, JM
    Bruguera, M
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (11) : 2704 - 2709
  • [50] Increase in lifetime adverse drug reactions and increased disease severity among patients who will start COX-2 agents: Quantitative assessment of confounding by indication in 6,689 RA and OA patients.
    Wolfe, F
    Flowers, N
    Burke, T
    Arguelles, L
    Pettitt, D
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S225 - S225